Telehealth Intervention for Disruptive Behavior in Autism (THRIVE-ASD Trial)
Palo Alto (17 mi)Age: < 18
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Waitlist Available
Sponsor: Medical University of South Carolina
No Placebo Group
Trial Summary
What is the purpose of this trial?The purpose of this research study is to evaluate a time-limited version of Parent Child Interaction Therapy (PCIT) delivered via telehealth for young children with autism spectrum disorder (ASD) and disruptive behavior problems. Families will be randomly assigned to receive 10 sessions of Tele-PCIT or Treatment as Usual. Families will complete a baseline assessment, a post-treatment assessment, and a 3-month follow-up.
Eligibility Criteria
This trial is for young children aged 2 to almost 7 with Autism Spectrum Disorder (ASD) who show disruptive behaviors. They must have a confirmed ASD diagnosis, understand language at a two-year-old level, come from low-income families on Medicaid, and not be on unstable psychotropic medications or exhibit severe self-injury.Inclusion Criteria
My child is between 2 and 6 years old.
I have been diagnosed with ASD through various assessments including ADOS-2.
My understanding of language is at least as good as a typical 2-year-old's.
Exclusion Criteria
I engage in severe self-harm.
Treatment Details
The study tests a short version of Parent Child Interaction Therapy (PCIT) done through telehealth against the usual treatment methods for managing disruptive behaviors in kids with ASD. Participants will be randomly placed into one of these two groups and assessed before, after treatment, and three months later.
2Treatment groups
Experimental Treatment
Active Control
Group I: Tele-PCIT (Parent-Child Interaction Therapy)Experimental Treatment1 Intervention
Group II: Treatment as UsualActive Control1 Intervention
Find a clinic near you
Research locations nearbySelect from list below to view details:
Medical University of South CarolinaCharleston, SC
Loading ...
Who is running the clinical trial?
Medical University of South CarolinaLead Sponsor
Health Resources and Services Administration (HRSA)Collaborator